pubmed-article:20400407 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:20400407 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
pubmed-article:20400407 | lifeskim:mentions | umls-concept:C0023884 | lld:lifeskim |
pubmed-article:20400407 | lifeskim:mentions | umls-concept:C0243009 | lld:lifeskim |
pubmed-article:20400407 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
pubmed-article:20400407 | lifeskim:mentions | umls-concept:C0600688 | lld:lifeskim |
pubmed-article:20400407 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
pubmed-article:20400407 | lifeskim:mentions | umls-concept:C1546988 | lld:lifeskim |
pubmed-article:20400407 | pubmed:issue | 1 | lld:pubmed |
pubmed-article:20400407 | pubmed:dateCreated | 2010-4-19 | lld:pubmed |
pubmed-article:20400407 | pubmed:abstractText | The TOSCANA study aimed to determine the relationship between CD4 cell counts and liver toxicity in patients undergoing treatment simplification or substitution with nevirapine due to the toxicity or poor tolerability of a previous regimen. | lld:pubmed |
pubmed-article:20400407 | pubmed:language | eng | lld:pubmed |
pubmed-article:20400407 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20400407 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:20400407 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20400407 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20400407 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20400407 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20400407 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:20400407 | pubmed:issn | 1528-4336 | lld:pubmed |
pubmed-article:20400407 | pubmed:author | pubmed-author:AntelaAntonio... | lld:pubmed |
pubmed-article:20400407 | pubmed:author | pubmed-author:MirallesCelia... | lld:pubmed |
pubmed-article:20400407 | pubmed:author | pubmed-author:OcampoAntonio... | lld:pubmed |
pubmed-article:20400407 | pubmed:author | pubmed-author:PrietoArturoA | lld:pubmed |
pubmed-article:20400407 | pubmed:author | pubmed-author:LosadaElenaE | lld:pubmed |
pubmed-article:20400407 | pubmed:author | pubmed-author:FernándezRica... | lld:pubmed |
pubmed-article:20400407 | pubmed:author | pubmed-author:RodríguezRaúl... | lld:pubmed |
pubmed-article:20400407 | pubmed:author | pubmed-author:LópezMaría... | lld:pubmed |
pubmed-article:20400407 | pubmed:author | pubmed-author:GómezRocíoR | lld:pubmed |
pubmed-article:20400407 | pubmed:author | pubmed-author:MariñoAnaA | lld:pubmed |
pubmed-article:20400407 | pubmed:author | pubmed-author:RodríguezAlfr... | lld:pubmed |
pubmed-article:20400407 | pubmed:author | pubmed-author:CorredoiraJua... | lld:pubmed |
pubmed-article:20400407 | pubmed:author | pubmed-author:NavalGenoveva... | lld:pubmed |
pubmed-article:20400407 | pubmed:author | pubmed-author:Gevihga... | lld:pubmed |
pubmed-article:20400407 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:20400407 | pubmed:volume | 11 | lld:pubmed |
pubmed-article:20400407 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:20400407 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:20400407 | pubmed:pagination | 11-7 | lld:pubmed |
pubmed-article:20400407 | pubmed:meshHeading | pubmed-meshheading:20400407... | lld:pubmed |
pubmed-article:20400407 | pubmed:meshHeading | pubmed-meshheading:20400407... | lld:pubmed |
pubmed-article:20400407 | pubmed:meshHeading | pubmed-meshheading:20400407... | lld:pubmed |
pubmed-article:20400407 | pubmed:meshHeading | pubmed-meshheading:20400407... | lld:pubmed |
pubmed-article:20400407 | pubmed:meshHeading | pubmed-meshheading:20400407... | lld:pubmed |
pubmed-article:20400407 | pubmed:meshHeading | pubmed-meshheading:20400407... | lld:pubmed |
pubmed-article:20400407 | pubmed:meshHeading | pubmed-meshheading:20400407... | lld:pubmed |
pubmed-article:20400407 | pubmed:meshHeading | pubmed-meshheading:20400407... | lld:pubmed |
pubmed-article:20400407 | pubmed:meshHeading | pubmed-meshheading:20400407... | lld:pubmed |
pubmed-article:20400407 | pubmed:meshHeading | pubmed-meshheading:20400407... | lld:pubmed |
pubmed-article:20400407 | pubmed:meshHeading | pubmed-meshheading:20400407... | lld:pubmed |
pubmed-article:20400407 | pubmed:meshHeading | pubmed-meshheading:20400407... | lld:pubmed |
pubmed-article:20400407 | pubmed:meshHeading | pubmed-meshheading:20400407... | lld:pubmed |
pubmed-article:20400407 | pubmed:meshHeading | pubmed-meshheading:20400407... | lld:pubmed |
pubmed-article:20400407 | pubmed:meshHeading | pubmed-meshheading:20400407... | lld:pubmed |
pubmed-article:20400407 | pubmed:articleTitle | Liver toxicity after switching or simplifying to nevirapine-based therapy is not related to CD4 cell counts: results of the TOSCANA study. | lld:pubmed |
pubmed-article:20400407 | pubmed:affiliation | Hospital Clínico Universitario de Santiago de Compostela, Spain. antonioantela@mundo-r.com | lld:pubmed |
pubmed-article:20400407 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:20400407 | pubmed:publicationType | Multicenter Study | lld:pubmed |